AU2003297356A8 - Prevention and treatment of cardiac arrhythmias - Google Patents
Prevention and treatment of cardiac arrhythmiasInfo
- Publication number
- AU2003297356A8 AU2003297356A8 AU2003297356A AU2003297356A AU2003297356A8 AU 2003297356 A8 AU2003297356 A8 AU 2003297356A8 AU 2003297356 A AU2003297356 A AU 2003297356A AU 2003297356 A AU2003297356 A AU 2003297356A AU 2003297356 A8 AU2003297356 A8 AU 2003297356A8
- Authority
- AU
- Australia
- Prior art keywords
- prevention
- treatment
- cardiac arrhythmias
- arrhythmias
- cardiac
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43450802P | 2002-12-17 | 2002-12-17 | |
US60/434,508 | 2002-12-17 | ||
US43488802P | 2002-12-19 | 2002-12-19 | |
US60/434,888 | 2002-12-19 | ||
PCT/US2003/040504 WO2004056313A2 (en) | 2002-12-17 | 2003-12-17 | Prevention and treatment of cardiac arrhythmias |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003297356A8 true AU2003297356A8 (en) | 2004-07-14 |
AU2003297356A1 AU2003297356A1 (en) | 2004-07-14 |
Family
ID=32685317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003297356A Abandoned AU2003297356A1 (en) | 2002-12-17 | 2003-12-17 | Prevention and treatment of cardiac arrhythmias |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1610811A4 (en) |
JP (1) | JP2006514035A (en) |
AU (1) | AU2003297356A1 (en) |
WO (1) | WO2004056313A2 (en) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8076288B2 (en) | 2004-02-11 | 2011-12-13 | Amylin Pharmaceuticals, Inc. | Hybrid polypeptides having glucose lowering activity |
WO2005077094A2 (en) | 2004-02-11 | 2005-08-25 | Amylin Pharmaceuticals, Inc. | Pancreatic polypeptide family motifs and polypeptides comprising the same |
US20090286723A1 (en) * | 2005-02-11 | 2009-11-19 | Amylin Pharmaceuticals, Inc. | Hybrid Polypeptides with Selectable Properties |
KR20070115947A (en) | 2005-02-11 | 2007-12-06 | 아밀린 파마슈티칼스, 인크. | Gip analog and hybrid polypeptides with selectable properties |
US8263545B2 (en) | 2005-02-11 | 2012-09-11 | Amylin Pharmaceuticals, Inc. | GIP analog and hybrid polypeptides with selectable properties |
WO2006110887A2 (en) * | 2005-04-11 | 2006-10-19 | Amylin Pharmaceuticals, Inc | Use of glp-1, exendin and agonists thereof to delay or prevent cardiac remodeling |
MX2008002028A (en) * | 2005-08-11 | 2008-03-27 | Amylin Pharmaceuticals Inc | Hybrid polypeptides with selectable properties. |
EA200870575A1 (en) * | 2006-05-26 | 2009-08-28 | Амилин Фармасьютикалз, Инк. | COMPOSITIONS AND METHODS OF TREATMENT OF CONSTITUAL HEART FAILURE |
US8497240B2 (en) | 2006-08-17 | 2013-07-30 | Amylin Pharmaceuticals, Llc | DPP-IV resistant GIP hybrid polypeptides with selectable properties |
RU2413528C2 (en) | 2007-01-18 | 2011-03-10 | Открытое Акционерное Общество "Валента Фармацевтика" | Exenatide and dalargin drug for treating diabetes, adminisration and therapy |
JP2009019027A (en) * | 2007-07-16 | 2009-01-29 | Hanmi Pharmaceutical Co Ltd | Insulin secretion peptide derivative in which amino acid of amino terminal is varied |
RU2010113997A (en) * | 2007-09-11 | 2011-10-20 | Мондобайотек Лабораториз Аг (Li) | THYROLIBERIN FOR THERAPEUTIC USE |
PT2373681T (en) | 2008-12-10 | 2017-04-11 | Glaxosmithkline Llc | Pharmaceutical compositions of albiglutide |
US8691763B2 (en) | 2010-05-04 | 2014-04-08 | Glaxosmithkline Llc | Methods for treating or preventing cardiovascular disorders and providing cardiovascular protection |
CN104039344A (en) * | 2011-10-28 | 2014-09-10 | 法瑞斯生物技术有限公司 | A polypeptide for the protection against heart ischemia-reperfusion injury |
UA116217C2 (en) | 2012-10-09 | 2018-02-26 | Санофі | Exendin-4 derivatives as dual glp1/glucagon agonists |
AR094181A1 (en) | 2012-12-21 | 2015-07-15 | Sanofi Sa | GLP1 / GIP OR TRIGONAL DUAL AGONISTS OF GLP1 / GIP / GLUCAGON |
EP3080150B1 (en) | 2013-12-13 | 2018-08-01 | Sanofi | Exendin-4 peptide analogues as dual glp-1/gip receptor agonists |
EP3080152A1 (en) | 2013-12-13 | 2016-10-19 | Sanofi | Non-acylated exendin-4 peptide analogues |
WO2015086733A1 (en) | 2013-12-13 | 2015-06-18 | Sanofi | Dual glp-1/glucagon receptor agonists |
EP3080154B1 (en) | 2013-12-13 | 2018-02-07 | Sanofi | Dual glp-1/gip receptor agonists |
TW201625670A (en) | 2014-04-07 | 2016-07-16 | 賽諾菲公司 | Dual GLP-1/glucagon receptor agonists derived from EXENDIN-4 |
TW201625668A (en) | 2014-04-07 | 2016-07-16 | 賽諾菲公司 | Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists |
TW201625669A (en) | 2014-04-07 | 2016-07-16 | 賽諾菲公司 | Peptidic dual GLP-1/glucagon receptor agonists derived from Exendin-4 |
US9932381B2 (en) | 2014-06-18 | 2018-04-03 | Sanofi | Exendin-4 derivatives as selective glucagon receptor agonists |
RU2573933C1 (en) | 2014-08-21 | 2016-01-27 | Дафот Энтерпрайсис Лимитед | Peptide for medical treatment of pancreatic diabetes of 2nd type and its complications |
AR105319A1 (en) | 2015-06-05 | 2017-09-27 | Sanofi Sa | PROPHARMS THAT INCLUDE A DUAL AGONIST GLU-1 / GLUCAGON CONJUGATE HIALURONIC ACID CONNECTOR |
AR105284A1 (en) | 2015-07-10 | 2017-09-20 | Sanofi Sa | DERIVATIVES OF EXENDINA-4 AS SPECIFIC DUAL PEPTIDE AGONISTS OF GLP-1 / GLUCAGÓN RECEPTORS |
CN111050750A (en) | 2017-08-24 | 2020-04-21 | 诺沃挪第克公司 | GLP-1 compositions and uses thereof |
CN108939052B (en) * | 2018-09-04 | 2021-03-16 | 江苏省中医药研究院 | Application of exenatide in preparation of medicine for preventing or treating atrial fibrillation |
KR20220143036A (en) | 2020-02-18 | 2022-10-24 | 노보 노르디스크 에이/에스 | pharmaceutical formulation |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6277819B1 (en) * | 1996-08-30 | 2001-08-21 | Eli Lilly And Company | Use of GLP-1 or analogs in treatment of myocardial infarction |
AU759058C (en) * | 1998-02-13 | 2005-09-15 | Amylin Pharmaceuticals, Inc. | Inotropic and diuretic effects of exendin and GLP-1 |
US6284725B1 (en) * | 1998-10-08 | 2001-09-04 | Bionebraska, Inc. | Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue |
WO2001087322A2 (en) * | 2000-05-17 | 2001-11-22 | Bionebraska, Inc. | Peptide pharmaceutical formulations |
ES2307619T3 (en) * | 2000-05-19 | 2008-12-01 | Amylin Pharmaceuticals, Inc. | TREATMENT OF THE ACUTE CORONARY SYNDROME WITH GLP-1. |
ES2347137T3 (en) * | 2000-10-20 | 2010-10-26 | Amylin Pharmaceuticals, Inc. | TREATMENT OF HIBERNANT MYIOCARD AND DIABETIC CARDIOMIOPATIA WITH A GPL-1 PEPTIDE |
WO2002085406A1 (en) * | 2001-04-24 | 2002-10-31 | Restoragen, Inc. | Methods and compositions for treating conditions associated with insulin resistance |
-
2003
- 2003-12-17 EP EP03813770A patent/EP1610811A4/en not_active Withdrawn
- 2003-12-17 AU AU2003297356A patent/AU2003297356A1/en not_active Abandoned
- 2003-12-17 WO PCT/US2003/040504 patent/WO2004056313A2/en active Application Filing
- 2003-12-17 JP JP2004562291A patent/JP2006514035A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2004056313A3 (en) | 2004-11-25 |
EP1610811A2 (en) | 2006-01-04 |
JP2006514035A (en) | 2006-04-27 |
EP1610811A4 (en) | 2008-03-26 |
AU2003297356A1 (en) | 2004-07-14 |
WO2004056313A2 (en) | 2004-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003297356A8 (en) | Prevention and treatment of cardiac arrhythmias | |
AU2003290548A8 (en) | Prevention and treatment of synucleinopathic disease | |
IL161957A0 (en) | Device and procedure to treat cardiac atrial arrhythmias | |
TWI347188B (en) | Treatment and prevention of osteoporosis | |
AU8880701A (en) | Cardiac arrhythmia treatment methods | |
IL164266A0 (en) | Treatment of gastroparesis | |
IL176027A0 (en) | Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure | |
EP1635801A4 (en) | Methods for treating and preventing cardiac arrhythmia | |
AU2003287354A8 (en) | An intracardiac catheter and method of use | |
AU2003268295A8 (en) | "diagnosis and treatment of infertility" | |
GB0213869D0 (en) | The treatment of pain | |
HUP0303306A3 (en) | Use of il-18 inhibitors for the treatment and/or prevention of heart disease | |
GB0211295D0 (en) | Treatment of pain | |
GB0115707D0 (en) | Treatment and prevention of lipodermatosclerosis | |
AU2003233681A8 (en) | Diagnosis and treatment of human dormancy syndrome | |
IL179561A0 (en) | Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias | |
AU2003231279A8 (en) | Prevention and treatment of type 2 diabetes | |
AU2003213898A1 (en) | Prevention and treatment of mycoplasma-associated diseases | |
GB0101146D0 (en) | Treatment of skin conditions | |
AU2003207315A1 (en) | Treatment of muscle damage | |
IL153485A0 (en) | New bispidine compounds and their use in the treatment of cardiac arrhythmias | |
EP1483407A4 (en) | Methods of therapy and diagnosis | |
GB0316940D0 (en) | Treatment of skin and other medical conditions | |
AU2003235665A8 (en) | Diagnostic and therapeutic uses of topors | |
EP1567863A4 (en) | Methods of therapy and diagnosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |